Discover Pharma - Connecting people with science

Welcome to Discover Pharma! Today is : April 25, 2026

DP Magazine HomeDebbie2025-10-10T16:39:02+01:00

Top News

Apr 24: NETRIS Pharma Nature publishes pancreatic cancer Phase 1b data showing NP137 survival and surgery gains

Apr 24: Myomaker Bio launches lab-grown human muscle platform for preclinical drug testing

Apr 24: Abivax to present nine obefazimod studies at DDW as Phase 3 ulcerative colitis data build

Apr 23: Viz.ai, Johnson & Johnson strike US chronic subdural hematoma AI deal

Apr 23: Veristat acquires Certara regulatory and medical writing business

Biotech,Clinical Trials,Drug Development,Oncology,Precision medicine,Research & Development
NETRIS Pharma Nature publishes pancreatic cancer Phase 1b data showing NP137 survival and surgery gains
By Liza Laws|Last Updated: 24 April 2026|

Biotech,Cell & Gene Therapy,Clinical Development,Drug discovery,Research & Development,Technology and platforms
Myomaker Bio launches lab-grown human muscle platform for preclinical drug testing

Biotech,Clinical Trials,European biotech,Events and Conferences,Gastroenterology
Abivax to present nine obefazimod studies at DDW as Phase 3 ulcerative colitis data build

top headlines

Clinical Development,Clinical studies,Digital Health,FDA,Medical devices,Technology and platforms
Viz.ai, Johnson & Johnson strike US chronic subdural hematoma AI deal
Viz.ai has entered a collaboration with Johnson & Johnson to [...]

April 22, 2026
Clinical Development,Data Management,Mergers & Acquisitions,Regulatory Affairs,Research & Development
Veristat acquires Certara regulatory and medical writing business
Veristat has agreed to acquire Certara’s regulatory and medical writing [...]

April 22, 2026

Movers & Shakers

sponsored content

Other news

CDMOs & Manufacturing,Facilities and infrastructure,Medical devices,Regulatory Affairs,Supply Chain & Logistics
Trelleborg gains ISO certification for Costa Rica medtech plant
Trelleborg Medical Solutions has secured ISO 13485:2016 certification for its [...]

read more
CDMOs & Manufacturing,Drug discovery,Ingredients,Manufacturing,Sustainability,Technology and platforms
Merck launches bio-based HPLC solvents for pharma labs
Merck has launched a portfolio of bio-based solvents for high-performance [...]

read more
Drug Delivery & Formulation,Drug Development,Oncology,Pharmaceuticals and therapeutics,Research & Development,Technology and platforms
ISS National Lab research advances DNA-inspired cancer nanomaterials for chemotherapy and immunotherapy development
Eascra Biotech is advancing DNA-inspired nanomaterials developed with ISS National [...]

read more
Biotech,Clinical Trials,Drug discovery,Funding,Oncology,Partnerships & Funding,Pharmaceuticals and therapeutics,Research & Development,Technology and platforms
Neomorph raises $100 million to advance NEO-811 Phase 1/2 cancer trial and molecular glue degrader pipeline
Neomorph has closed a $100 million Series B financing to [...]

read more
Cardiovascular diseases,Chronic diseases,Market Access & Commercialization,Pharmaceuticals and therapeutics,Regulatory Affairs
NICE expands Lokelma access for hyperkalaemia after draft recommendation
The National Institute for Health and Care Excellence (NICE) has [...]

read more
CDMOs & Manufacturing,Drug Development,European biotech,Logistics and distribution,Oncology,Partnerships & Funding,Supply Chain & Logistics
Oncodesign expands ARRONAX deal to secure astatine-211 supply for radiotherapy research
Oncodesign Services has expanded its collaboration with French research institute [...]

read more

Mail Icon

news via inbox

Sign up for our newsletter and get the latest news right in your inbox